Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Cencora, Inc.

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Pharmaceutical Distribution Services Segment Operating Income

Pharmaceutical Distribution Services Segment Operating Income % Chg.

Pharmaceutical Distribution Services Segment Operating Income Common Size

Total Other Segment Operating Income

Total Other Segment Operating Income % Chg.

Total Other Segment Operating Income Common Size

US Healthcare Solutions Operating Income

US Healthcare Solutions Operating Income % Chg.

US Healthcare Solutions Operating Income Common Size

International Healthcare Solutions Operating Income

International Healthcare Solutions Operating Income % Chg.

International Healthcare Solutions Operating Income Common Size

Other EBIT

Other EBIT % Chg.

Other EBIT Common Size

Total EBIT

Total EBIT Common Size

Total EBIT % Chg.

US Human Health Revenue

US Human Health Revenue % Chg.

US Human Health Revenue Common Size

US Animal Health Revenue

US Animal Health Revenue % Chg.

US Animal Health Revenue Common Size

Total US Healthcare Solutions Revenue

Total US Healthcare Solutions Revenue % Chg.

Total US Healthcare Solutions Revenue Common Size

International Alliance Healthcare Revenue

International Alliance Healthcare Revenue % Chg.

International Alliance Healthcare Revenue Common Size

Total International Healthcare Solutions Revenue

Total International Healthcare Solutions Revenue % Chg.

Total International Healthcare Solutions Revenue Common Size

Other Revenue

Other Revenue % Chg.

Other Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Revenue	Sep '25	Sep '24
US Human Health Revenue	285,287.5	259,973.9
US Animal Health Revenue	5,694.5	5,365.5
Total US Healthcare Solutions Revenue	290,982	265,339.4
International Alliance Healthcare Revenue	24,394.8	23,061.7
Other Healthcare Solutions Revenue	5,971.5	5,565.8
Total International Healthcare Solutions Revenue	30,366.3	28,627.5
Other Revenue	-15.5	-8.4
Total Revenue	321,332.8	293,958.6

EBIT	Sep '25	Sep '24
Pharmaceutical Distribution Services Segment Operating Income	—	—
Total Other Segment Operating Income	—	—
US Healthcare Solutions Operating Income	3,574.7	2,934.9
International Healthcare Solutions Operating Income	648.3	713.4
Other EBIT	-1,594.4	-1,473
Total EBIT	2,628.6	2,175.2